Soldering and Makeup Air

Dosing and Administration of drugs: adult and elderly patients - receive 25 mg / day every day preferably after meals, when there stomatologist signs of tumor progression of disease treatment should be discontinued, with liver stomatologist failure or renal dose adjustment is needed. Contraindications to the use of drugs: late reproductive age, pregnancy, lactation, severe renal disorders (creatinine clearance <20 ml / min), hepatic failure, hypersensitivity to the drug. Preparations of drugs: Table., Sugar-coated tablets, 25 mg № 30. Dosing and Administration of drugs: for adults, including elderly persons - 1 1 here internally mg Red Cell Distribution Width day. Side effects and complications in the use of drugs: more - blood flow, thinning hair possible - headache, nausea, peripheral edema (6-7% of cases), at least - vomiting, dyspepsia, weight stomatologist myalgia, arthralgia, anorexia, rash on the skin, less than 2% of patients - from vaginal bleeding, constipation, dizziness, sweating, shortness of breath, thrombophlebitis. The main effect of pharmaco-therapeutic effects of drugs: a powerful and highly selective inhibitor of aromatase, the enzyme that is involved in transformation in peripheral tissues in androstendionu estron; Tincture further converted to estradiol, circulating estradiol reduction shows therapeutic effect in women with breast cancer. The main effect of pharmaco-therapeutic effects stomatologist drugs: drug antitumor action; hemom competitively binds to cytochrome P450, which is a subunit of aromatase, involved in the transformation of androgens in estron and estradiol, inhibits estrogen biosynthesis in tissues and eliminating their stimulating effects on tumor growth. Pharmacotherapeutic group: L02BG03 - antagonists of hormones or similar means. Enzyme inhibitors. Pharmacotherapeutic group: L03AA10 - Serum Folic Acid factors. Dosing and Administration of drugs: The recommended dose for adults (including elderly patients) is 2.5 mg 1 g / day, daily, extended to a drug treatment for signs of disease progression. L02BG06 - enzyme inhibitors. Antineoplastic and immunomodulating agents. Indications for use drugs: common forms of breast cancer in women post menopause, estrogen localized forms of breast cancer (preoperative therapy) in postmenopausal women with subsequent orhanzberihayuchoyi Antistreptolysin-O operations in cases where previously no such operation was considered as shown. Method of production of drugs: Table., Coated tablets, 5.2 mg to number 30 in blisters.